Features
Drug & Device News
Several items of key importance are discussed.
Features
Understanding the Basics of Nursing Home Negligence Matters
Nursing-home negligence claims are on the rise. Here are the types of claims are most plaintiff attorneys likely to see, and some of the basics they should know about them.
Social Security Determinations
In a medical malpractice litigation, should a Social Security Administration (SSA) determination of disability be admitted as evidence? A look at a recent court case.
The Conflict over Medicare's 'Full Reimbursement' Rule
If the Medicare beneficiary compromises the tort claim and recovers a reduced amount from the tortfeasor for medical expenses,is the government entitled to full reimbursement of its Medicare payments, or is it entitled (like its beneficiary) to only a proportionate recovery from the settlement?
Features
Drug & Device News
Recent news of importance to you and your practice.
Features
Gathering Evidence in Qui Tam Actions
According to the federal government, while the act of gathering evidence creates a direct conflict between competing interests, the interest in disclosing the fraud generally outweighs the defendant's interest in keeping the fraud from being divulged.
New Drug Battle Rises in D.C.
A series of new DES cases proceeding in federal district courts in the District of Columbia and Boston is bringing a relatively untested issue in DES litigation to the forefront.
Features
Journal Article's Authors Not Responsible for Loss of Claim
Are there, or should there be, legal consequences for authors and publishers when medical journal articles do not state the truth, thereby causing harm?
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Protecting Innovation in the Cyber World from Patent TrollsWith trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.Read More ›
- Meet the Lawyer Working on Inclusion Rider LanguageAt the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers & Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›